Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Sight Sciences, Inc. (SGHT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"Condensed Consolidated Balance Sheets June 30, December 31, 2023 2022 Assets Current assets: Cash and cash equivalents $ 154,515 $ 185,000 Accounts receivable, net of allowance for credit losses of $1,037 and $1,024 at June 30, 2023 and December 31, 2022, respectively 18,103 15,148 Inventory, net 7,907 6,114 Prepaid expenses and other current assets 1,795 3,415 Total current assets 182,320 209,677 Property and equipment, net 1,477 1,571 Operating lease right-of-use assets 1,125 1,614 Other noncurrent assets 367 211 Total assets $ 185,289 $ 213,073 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,947 $ 2,688 Accrued compensation 5,720 7,352 Accrued and other current liabilities 5,386 7,777 Total current liabilities 14,053 17,817 Long-term debt 33,607 33,313 Ot...",
"DELIVERING THE POWER OF SIGHT" |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/12/2023 |
4
| Schroeder Valeska (Director) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 11,940 shares
@ $0 |
|
| 06/12/2023 |
4
| Rogers Erica J. (Director) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 11,940 shares
@ $0
Granted 15,094 shares
@ $0 |
|
| 06/12/2023 |
4
| Zurbay Donald (Director) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 11,940 shares
@ $0
Granted 15,094 shares
@ $0 |
|
| 06/12/2023 |
4
| Fountain Tamara (Director) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 15,094 shares
@ $0 |
|
| 06/12/2023 |
4
| Encrantz Staffan (10% Owner) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 11,940 shares
@ $0
Granted 15,094 shares
@ $0 |
|
| 06/12/2023 |
4
| Larsen-Becker Brenda Jane (Director) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 17,923 shares
@ $0
Paid exercise price by delivering 2,295 shares
@ $9.083, valued at
$20.8k
Granted 15,094 shares
@ $0 |
|
| 06/12/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/09/2023 |
8-K
| Regulation FD Disclosure, Other Events Interactive Data |
| 06/02/2023 |
8-K
| Regulation FD Disclosure, Other Events Interactive Data |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/25/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/11/2023 |
4
| Bauerlein Alison (See Remarks) has filed a Form 4 on Sight Sciences, Inc.|
Txns:
| Granted 103,000 shares
@ $0
Granted 71,800 options to buy
@ $10.1, valued at
$725.2k
|
|
| 05/08/2023 |
8-K
| Investor presentation |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/26/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/05/2023 |
3
| Bauerlein Alison (See remarks) has filed a Form 3 on Sight Sciences, Inc. |
| 04/03/2023 |
8-K
| Investor presentation |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/16/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/16/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/13/2023 |
8-K
| Quarterly results|
Docs:
|
"SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 185,000 $ 260,687 Accounts receivable, net 15,148 8,709 Inventory, net 6,114 3,475 Prepaid expenses and other current assets 3,415 4,164 Total current assets 209,677 277,035 Property and equipment, net 1,571 1,454 Operating lease right-of-use assets 1,614 1,495 Other noncurrent assets 211 202 Total assets $ 213,073 $ 280,186 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,688 $ 3,351 Accrued compensation 7,352 5,987 Accrued and other current liabilities 7,777 4,166 Total current liabilities 17,817 13,504 Long-term debt 33,313 32,656 Other noncurrent liabilities 1,867 1,919 Total liabilities 52,997 48,079 Commitment..." |
|
| 02/14/2023 |
SC 13G/A
| Badawi Paul reports a 11.8% stake in Sight Sciences, Inc. |
| 02/14/2023 |
SC 13G/A
| HEP Partners LLC reports a 1.3% stake in Sight Sciences, Inc. |
|
|
|